COMMUNIQUÉS West-GlobeNewswire

-
HealthLynked Engages Meridian Group to Accelerate Strategic Partnerships and Revenue Growth
15/07/2025 -
Extendicare Announces July 2025 Dividend of C$0.042 per Share
15/07/2025 -
OncoC4 to Present at the 2025 Orphan Drug Summit on Strategies to Eliminate Anti-Drug Antibodies in Orphan Therapies
15/07/2025 -
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
15/07/2025 -
Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide
15/07/2025 -
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
15/07/2025 -
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
15/07/2025 -
Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled
15/07/2025 -
IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan
15/07/2025 -
MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy
15/07/2025 -
Sienna Announces July Dividend
15/07/2025 -
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
15/07/2025 -
SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System
15/07/2025 -
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices
15/07/2025 -
Beverly Hills MD Launches Metabolic Reset: A Revolutionary Weight Management Support Formula
15/07/2025 -
Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation
15/07/2025 -
Myriad Genetics Earns 2025 Great Place To Work Certification™
15/07/2025 -
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
15/07/2025 -
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
15/07/2025
Pages